Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
11.45
-0.17 (-1.47%)
Nov 21, 2024, 3:54 PM EST - Market closed
Third Harmonic Bio Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$20.33
Upside
+77.55%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $12 → $20 | Hold → Buy | Upgrades | $12 → $20 | +74.67% | Aug 9, 2024 |
Stifel | Stifel | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +100.87% | Jun 18, 2024 |
Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +57.21% | Jun 7, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $5 → $7 | Hold | Maintains | $5 → $7 | -38.86% | Aug 11, 2023 |
Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $34 → $5 | Buy → Hold | Downgrades | $34 → $5 | -56.33% | Dec 16, 2022 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $30 → $3.6 | Strong Buy → Hold | Downgrades | $30 → $3.6 | -68.56% | Dec 16, 2022 |
Jefferies | Jefferies | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +162.01% | Oct 10, 2022 |
Morgan Stanley | Morgan Stanley | Buy Initiates $34 | Buy | Initiates | $34 | +196.94% | Oct 10, 2022 |
Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 10, 2022 |